Luckily doc, my aapl calls may cover that if it go
Post# of 36568
(Total Views: 295)
Posted On: 08/24/2020 2:07:43 PM
Luckily doc, my aapl calls may cover that if it goes to $600 in the next 2 weeks, or $150 post split.
Of the 400M, I thought (and would have to go back and read the form 10 again) existing shareholders have about 8%, and Friends of Generex have 1-2%, so GNBT has 90%. Initially the talk was GNBT holding 70% after the listing, so maybe selling 20% to institutions during the IPO. That would be about 80M shares being sold. So if they can get your $10/share (which recent IPOs like CVAC got $16 for 13.3M shares sold to institutions out of their 176M, so less than 10%), then that is $800M to GNBT which would fund EVERYTHING without more dilution. That would also give NGIO a $4B valuation, whereas CVAC is at $11B without all the potential products NGIO has to offer.
Of the 400M, I thought (and would have to go back and read the form 10 again) existing shareholders have about 8%, and Friends of Generex have 1-2%, so GNBT has 90%. Initially the talk was GNBT holding 70% after the listing, so maybe selling 20% to institutions during the IPO. That would be about 80M shares being sold. So if they can get your $10/share (which recent IPOs like CVAC got $16 for 13.3M shares sold to institutions out of their 176M, so less than 10%), then that is $800M to GNBT which would fund EVERYTHING without more dilution. That would also give NGIO a $4B valuation, whereas CVAC is at $11B without all the potential products NGIO has to offer.
(2)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Disclaimer: Of course, all of this is my opinion and you should not make any investment decisions based on my opinion. I have not received any non-public information.